Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Anaesthesia and Intensive Care|June 2, 2016
The effect of augmenting early nutritional energy delivery on quality of life and employment status one year after ICU admissionD B Reid, L S Chapple, S N O'Connor, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|December 9, 2020
Use of a High-Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-Group, Feasibility TrialLee-Anne S Chapple, Matthew J Summers, Rinaldo Bellomo, et al.
Blood|September 25, 2003
Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibodyPeter A Smethurst, Lotta Joutsi-Korhonen, Marie N O'Connor, et al.
Blood|December 26, 2008
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteinsMarie N O'Connor, Isabelle I Salles, Ana Cvejic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2025
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive SubtypesDavid J Papke, John S A Chrisinger, Christopher A French, et al.
Med (New York, N.Y.)|May 19, 2022
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potencyMarie N O'Connor, David M Kallenberg, Carlotta Camilli, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trialMatthew J Summers, Lee-Anne S Chapple, Rinaldo Bellomo, et al.
JAMA|June 11, 2025
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical TrialMatthew J Summers, Lee-Anne S Chapple, Amalia Karahalios, et al.
Cancer Discovery|February 9, 2022
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene RearrangementsAlison M Schram, Igor Odintsov, Madelyn Espinosa-Cotton, et al.
Pageof 25